4CPS-121 Impact of pharmaceutical consultations for new oral oncology agents

BACKGROUND: Pharmaceutical consultations are organised in the Department of Oncology when new oral anticancer drugs are prescribed. Drug-drug interactions (DDI) and drug-food interactions are frequent with these new drugs and can produce serious adverse events (SAE). Due to the chronicity of the dis...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Eur J Hosp Pharm
Autores principales: Talarmin, C, Grajozsex, M, Houari, S, Clou, E, Fillon, J, Tendjaoui, F, Grazziotin-Soares, D, Lotz, JP, Gohari, A, Debrix, I
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Group 2018
Materias:
Section 4: Clinical pharmacy services
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535313/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.212
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares